- OT
- View all news
- Newmedica supports vision research charity
Newmedica supports vision research charity
The eye hospital has pledged to match-fund donations made to Sight Research UK’s Christmas Appeal
03 December 2024
Eye hospital Newmedica has partnered with Sight Research UK to raise funds to support research into eye diseases over the festive period.
Supporting the charity’s Brightening lives through vision research Christmas Appeal, Newmedica has pledged to match any donations made to Sight Research UK up to the value of £10,000.
Sight Research UK’s Christmas Appeal is designed to raise funds to sustain its sight-saving research.
The charity’s appeal website explains that donations will go towards supporting vital future research projects.
“Whether it is through enhanced diagnostic tools, improved treatments, or even prevention, with your support, these projects have the potential to transform lives threatened by sight loss,” the website adds.
Speaking about the partnership, chief executive at Sight Research UK, Charlotte Parkin, said: “We are absolutely thrilled to have the support of Newmedica for the 2024 Sight Research UK Christmas campaign. This year our campaign aims to raise vital funds to ensure we can continue our mission to fight eye disease through research.”
She added: “We are immensely grateful for Newmedica’s contribution and our shared endeavour to improve the lives of those living with sight loss.”
Managing director of Newmedica, Rebecca Lythe, said the organisation was proud to be part of this important initiative helping to raise the vital funds needed to advance the fight against eye disease.
She added: “We share Sight Research UK’s commitment to improving patient outcomes and making a lasting impact on the lives of those affected by sight loss. Through our pledge to match Christmas donations up to £10,000, we hope to double the difference this campaign can make.”
To learn more about the appeal, visit Sight Research UK’s website.
- Explore more topics
- NHS and health
- Charity
Comments (0)
You must be logged in to join the discussion. Log in